(Q30845414)

27 June 2017

title

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides (English)

1 reference

27 June 2017

1 reference

1 reference

1 reference

3

Edward Rockenstein

1 reference

27 June 2017

6

Eliezer Masliah

1 reference

27 June 2017

Manfred Windisch

1

1 reference

27 June 2017

Birgit Hutter-Paier

series ordinal

2

1 reference

27 June 2017

Makoto Hashimoto

series ordinal

4

1 reference

27 June 2017

Margaret Mallory

series ordinal

5

1 reference

27 June 2017

publication date

1 August 2002

1 reference

Journal of Molecular Neuroscience

27 June 2017

published in

1 reference

27 June 2017

volume

19

1 reference

27 June 2017

issue

1-2

1 reference

27 June 2017

page(s)

63-69

1 reference

Cognitive function and the costs of Alzheimer disease. An exploratory study

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0012-8

Properties of NACP/alpha-synuclein and its role in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0012-8

Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0012-8

Genetic epidemiology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0012-8

Prevalence of depression in Alzheimer's disease and validity of Research Diagnostic Criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0012-8

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

12 December 2020

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation

1 reference

12 December 2020

Identification of two distinct synucleins from human brain

1 reference

12 December 2020

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

12 December 2020

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs

1 reference

12 December 2020

Epidemiology of major age-related diseases in women compared to men.

1 reference

12 December 2020

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

1 reference

12 December 2020

Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing

1 reference

12 December 2020

alpha-Synuclein and Parkinson's disease.

1 reference

12 December 2020

Depressive symptoms in Alzheimer's disease and multi-infarct dementia

1 reference

12 December 2020

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

1 reference

12 December 2020

Alpha-synuclein in Lewy body disease and Alzheimer's disease

1 reference

12 December 2020

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

12 December 2020

Protein aggregation in Huntington's and Parkinson's disease: implications for therapy.

1 reference

12 December 2020

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

12 December 2020

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders

1 reference

12 December 2020

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

12 December 2020

Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects

1 reference

12 December 2020

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

12 December 2020

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

1 reference

12 December 2020

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

1 reference

12 December 2020

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

1 reference

12 December 2020

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

12 December 2020

Depressive symptoms in Alzheimer disease: assessment and determinants.

1 reference

12 December 2020

1 reference

12 December 2020

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

1 reference

12 December 2020

Neuropathology of synuclein aggregates

1 reference

12 December 2020

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

1 reference

12 December 2020

Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic

1 reference

12 December 2020

Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Alpha-synuclein in Lewy bodies

1 reference

12 December 2020

A Drosophila model of Parkinson's disease

1 reference

12 December 2020

Donepezil in the treatment of Alzheimer disease.

1 reference

12 December 2020

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

1 reference

12 December 2020

Alpha-synuclein and Parkinson's disease: selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo

1 reference

12 December 2020

1 reference

12 December 2020

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

12 December 2020

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

1 reference

12 December 2020

Synaptic and neuritic alterations during the progression of Alzheimer's disease

1 reference

12 December 2020

Synoretin--A new protein belonging to the synuclein family

1 reference

12 December 2020

Mechanisms of neurodegenerative disorders: Part 1: protein aggregates.

1 reference

12 December 2020

10.1007/S12031-002-0012-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 June 2017

1019425965

0 references

1 reference